CoChat

A Prospective Clinical Trial of a Real-Time Polymerase Chain Reaction Assay for the Diagnosis of Candidemia in Nonneutropenic, Critically Ill Adults

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Invasive Candida infection among nonneutropenic, critically ill adults is a clinical problem that has received increasing attention in recent years. Poor performance of extant diagnostic modalities has promoted risk-based, preemptive prescribing in view of the poor outcomes associated with inadequate or delayed antifungal therapy; this risks unnecessary overtreatment. A rapid, reliable diagnostic test could have a substantial impact on therapeutic practice in this patient population. METHODS: Three TaqMan-based real-time polymerase chain reaction assays were developed that are capable of detecting the main medically important Candida species, categorized according to the likelihood of fluconazole susceptibility. Assay 1 detected Candida albicans, Candida parapsilosis, Candida tropicalis, and Candida dubliniensis. Assays 2 and 3 detected Candida glabrata and Candida krusei, respectively. The clinical performance of these assays, applied to serum, was evaluated in a prospective trial of nonneutropenic adults in a single intensive care unit. RESULTS: In all, 527 specimens were obtained from 157 participants. All 3 assays were run in parallel for each specimen; they could be completed within 1 working day. Of these, 23 specimens were obtained from 23 participants categorized as having proven Candida infection at the time of sampling. If a single episode of Candida famata candidemia was excluded, the estimated clinical sensitivity, specificity, and positive and negative predictive values of the assays in this trial were 90.9%, 100%, 100% and 99.8%, respectively. CONCLUSIONS: These data suggest that the described assays perform well in this population for enhancing the diagnosis of candidemia. The extent to which they may affect clinical outcomes, prescribing practice, and cost-effectiveness of care remains to be ascertained.

Overview

Integrity signals

Registry

Crossref · 10.1086/528690

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 1

  1. Iruretagoyena, 2000, Revista iberoamericana de micolog a : rgano de la Asociaci n Espa ola de Especialistas en Micolog a, 17, 93

Cited by

See all 158

Metadata

Authors
McMullan, R., Metwally, L., Coyle, P. V., Hedderwick, S., McCloskey, B., O'Neill, H. J., Patterson, C. C., Thompson, G., Webb, C. H., & Hay, R. J.
Affiliations
Queen's University Belfast (GB)
Corresponding author
McMullan, R.
Venue
Clinical Infectious Diseases
Published
2008-03-15
Volume
46
Issue
6
Pages
890-896
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2166806680
Cited by
145
References
35
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 5 · 2022: 1 · 2021: 4 · 2020: 5 · 2019: 5 · 2018: 2 · 2017: 5 · 2016: 6 · 2015: 8 · 2014: 11 · 2013: 16 · 2012: 6
FWCI
14.57
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (Queen's University Belfast) (submittedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
  • Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
Keywords
candidemia, real-time PCR, TaqMan real-time PCR, non-neutropenic patients, critically ill adults, intensive care unit, Candida albicans, Candida parapsilosis, Candida tropicalis, Candida dubliniensis, Candida glabrata, Candida krusei, serum biomarkers, sensitivity and specificity, antifungal therapy, fluconazole susceptibility
MeSH terms
Adult, Candida, Candidiasis, Female, Humans, Male, Predictive Value of Tests, Research Design, Sensitivity and Specificity, Polymerase Chain Reaction, Fungemia, Critical Illness, DNA Primers, Taq Polymerase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.